Djordje Atanackovic

8.0k total citations
142 papers, 4.4k citations indexed

About

Djordje Atanackovic is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Djordje Atanackovic has authored 142 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 75 papers in Immunology and 48 papers in Hematology. Recurrent topics in Djordje Atanackovic's work include Immunotherapy and Immune Responses (49 papers), Multiple Myeloma Research and Treatments (42 papers) and CAR-T cell therapy research (35 papers). Djordje Atanackovic is often cited by papers focused on Immunotherapy and Immune Responses (49 papers), Multiple Myeloma Research and Treatments (42 papers) and CAR-T cell therapy research (35 papers). Djordje Atanackovic collaborates with scholars based in Germany, United States and Italy. Djordje Atanackovic's co-authors include Tim Luetkens, Carsten Bokemeyer, Nicolaus Kröger, Yanran Cao, Katrin Bartels, York Hildebrandt, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic and Susanna Hegewisch‐Becker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Djordje Atanackovic

139 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Djordje Atanackovic Germany	43	2.1k	2.1k	1.6k	1.2k	414	142	4.4k
Frances T. Hakim United States	31	2.9k 1.4×	2.1k 1.0×	1.2k 0.7×	1.8k 1.5×	317 0.8×	82	5.7k
Joannes F.M. Jacobs Netherlands	33	2.0k 1.0×	1.7k 0.8×	1.2k 0.7×	537 0.4×	234 0.6×	98	3.9k
Lawrence G. Lum United States	39	2.2k 1.0×	1.9k 0.9×	1.0k 0.7×	971 0.8×	298 0.7×	212	4.7k
Andreas Beilhack Germany	32	2.6k 1.2×	1.3k 0.6×	1.2k 0.7×	1.4k 1.2×	149 0.4×	120	4.8k
Halvard Bönig Germany	39	1.4k 0.7×	1.7k 0.8×	1.4k 0.9×	1.6k 1.3×	207 0.5×	210	4.7k
Robert M. Verdijk Netherlands	36	1.4k 0.7×	1.0k 0.5×	1.2k 0.8×	321 0.3×	340 0.8×	194	4.7k
Daniel H. Fowler United States	33	2.2k 1.1×	1.2k 0.6×	737 0.5×	1.5k 1.2×	293 0.7×	140	4.2k
Lei Ding China	31	1.9k 0.9×	998 0.5×	2.1k 1.3×	2.6k 2.2×	409 1.0×	89	5.9k
Linda J. Bendall Australia	31	1.6k 0.8×	1.6k 0.8×	1.6k 1.0×	1.7k 1.4×	230 0.6×	79	4.9k
Segundo González Spain	44	3.5k 1.7×	1.6k 0.8×	845 0.5×	648 0.5×	162 0.4×	109	5.2k

Countries citing papers authored by Djordje Atanackovic

Since Specialization

Citations

This map shows the geographic impact of Djordje Atanackovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Djordje Atanackovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Djordje Atanackovic more than expected).

Fields of papers citing papers by Djordje Atanackovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Djordje Atanackovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Djordje Atanackovic. The network helps show where Djordje Atanackovic may publish in the future.

Co-authorship network of co-authors of Djordje Atanackovic

This figure shows the co-authorship network connecting the top 25 collaborators of Djordje Atanackovic. A scholar is included among the top collaborators of Djordje Atanackovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Djordje Atanackovic. Djordje Atanackovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, David, Olga Goloubeva, Aaron P. Rapoport, et al.. (2025). CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant. Clinical Lymphoma Myeloma & Leukemia. 25(6). 432–439. 1 indexed citations

Kocoglu, Mehmet H., Tim Luetkens, Jacqueline Bork, et al.. (2024). Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells. Blood Advances. 8(22). 5880–5884.

Atanackovic, Djordje, Xiaoxuan Fan, Mehmet H. Kocoglu, et al.. (2024). A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products. Cytotherapy. 26(4). 318–324. 2 indexed citations

Sunshine, Sarah B., et al.. (2023). 383 A Pilot Study of Tear Cytokine Profiling in a Patient with Ocular Graft versus Host Disease. Journal of Clinical and Translational Science. 7(s1). 113–114. 1 indexed citations

Cao, Xuefang, et al.. (2023). Tear cytokine profiling for ocular graft versus host disease utilizing a new multiplex assay. The Journal of Immunology. 210(Supplement_1). 173.41–173.41. 2 indexed citations

Mause, Erica R. Vander, Jillian M. Baker, Sabarinath Venniyil Radhakrishnan, et al.. (2023). Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Science Translational Medicine. 15(705). eadd7900–eadd7900. 17 indexed citations

Bisht, Kamlesh, Taro Fukao, Marielle Chiron, et al.. (2023). Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma. Cancer Medicine. 12(20). 20332–20352. 23 indexed citations

Mause, Erica R. Vander, Djordje Atanackovic, Carol S. Lim, & Tim Luetkens. (2022). Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity. Trends in biotechnology. 40(7). 875–890. 25 indexed citations

Atanackovic, Djordje, Forat Lutfi, Diego de Miguel‐Pérez, et al.. (2021). Deep dissection of the antiviral immune profile of patients with COVID-19. Communications Biology. 4(1). 1389–1389. 6 indexed citations

10.

Atanackovic, Djordje, Tim Luetkens, Nancy M. Hardy, et al.. (2021). Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant. Vaccines. 9(7). 737–737. 2 indexed citations

11.

Dizier, Benjamin, Andrea Callegaro, Muriel Debois, et al.. (2019). A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(7). 1725–1735. 13 indexed citations

12.

Luetkens, Tim, et al.. (2017). In Vivo Vaccination Effect in Clinical Responders to Anti-Myeloma Monoclonal Antibody Isatuximab. Blood. 130. 1830–1830. 4 indexed citations

13.

Radhakrishnan, Sabarinath Venniyil, et al.. (2017). Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma. Blood. 130. 3142–3142. 15 indexed citations

14.

Suling, Anna, Karin Oechsle, Anja Mehnert, et al.. (2016). Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study. BMC Palliative Care. 15(1). 25–25. 9 indexed citations

15.

Pujol, Jean-Louis, Johan Vansteenkiste, Tommaso Martino De Pas, et al.. (2015). Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(10). 1458–1467. 51 indexed citations

16.

Harbaum, Lars, Andreas H. Marx, Eray Goekkurt, Philippe Schafhausen, & Djordje Atanackovic. (2013). Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity. International Journal of Hematology. 99(1). 91–94. 10 indexed citations

17.

Atanackovic, Djordje, Tim Luetkens, Jens Panse, et al.. (2008). CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Haematologica. 93(3). 423–430. 53 indexed citations

18.

Atanackovic, Djordje, Nasser K. Altorki, Elisabeth Stockert, et al.. (2004). Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients. The Journal of Immunology. 172(5). 3289–3296. 148 indexed citations

19.

Gnjatic, Sacha, Djordje Atanackovic, Mitsutoshi Matsuo, et al.. (2003). Cross-Presentation of HLA Class I Epitopes from Exogenous NY-ESO-1 Polypeptides by Nonprofessional APCs. The Journal of Immunology. 170(3). 1191–1196. 49 indexed citations

20.

Gnjatic, Sacha, Djordje Atanackovic, Elke Jäger, et al.. (2003). Survey of naturally occurring CD4 ⁺ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses. Proceedings of the National Academy of Sciences. 100(15). 8862–8867. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact